Stock ATOMT ATOMTRACE
Add to a list
To use this feature you must be a member
Log inSign up

Financials AtomTrace

Equities

ATOMT

CZ0009004792

Advanced Medical Equipment & Technology

End-of-day quote Prague S.E.
Other stock markets
 23:00:00 13/05/2024 BST 		5-day change 1st Jan Change
41 CZK 0.00% Intraday chart for AtomTrace +13.89% -6.82%
2023 AtomTrace a.s. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
2022 AtomTrace a.s. Reports Earnings Results for the Full Year Ended December 31, 2021 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022
Capitalization 1 - - 173.6 173.6
Enterprise Value (EV) 1 - - 191.1 181.1
P/E ratio -11.7 x -9.65 x -8.68 x -9.51 x
Yield - - - -
Capitalization / Revenue - - 34.6 x 1,249 x
EV / Revenue - - 38.1 x 1,303 x
EV / EBITDA - - -9.91 x -10.1 x
EV / FCF - - -16.9 x -12.4 x
FCF Yield - - -5.93% -8.07%
Price to Book -75.8 x -205 x -8.69 x 8.14 x
Nbr of stocks (in thousands) - - 4,340 4,340
Reference price 2 45.00 37.50 40.00 40.00
Announcement Date 02/07/20 22/06/21 27/07/22 06/11/23
1CZK in Million2CZK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 17.28 0.328 3.066 4.259 5.02 0.139
EBITDA 1 7.663 -9.411 -8.226 -16.24 -19.29 -17.85
EBIT 1 7.328 -9.701 -8.436 -16.47 -19.51 -17.97
Operating Margin 42.4% -2,957.62% -275.15% -386.66% -388.63% -12,930.22%
Earnings before Tax (EBT) 1 7.492 -9.81 -8.36 -16.87 -20.16 -18.39
Net income 1 6.924 -9.81 -8.36 -16.87 -20.16 -18.39
Net margin 40.07% -2,990.85% -272.67% -396.01% -401.53% -13,230.94%
EPS 2 3.462 -4.521 -3.853 -3.886 -4.609 -4.206
Free Cash Flow 1 4.078 -3.859 -4.622 -9.762 -11.34 -14.61
FCF margin 23.6% -1,176.45% -150.75% -229.22% -225.8% -10,511.87%
FCF Conversion (EBITDA) 53.21% - - - - -
FCF Conversion (Net income) 58.89% - - - - -
Dividend per Share - - - - - -
Announcement Date 02/11/18 29/07/19 02/07/20 22/06/21 27/07/22 06/11/23
1CZK in Million2CZK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - 0.05 - 17.5 7.51
Net Cash position 1 6.77 7.23 - 0.69 - -
Leverage (Debt/EBITDA) - - -0.006321 x - -0.905 x -0.4208 x
Free Cash Flow 1 4.08 -3.86 -4.62 -9.76 -11.3 -14.6
ROE (net income / shareholders' equity) 129% -124% -289% 1,620% 193% -2,711%
ROA (Net income/ Total Assets) 70.6% -56.4% -63.3% -233% -181% -46.6%
Assets 1 9.805 17.4 13.22 7.226 11.12 39.47
Book Value Per Share 2 4.360 3.260 -0.5900 -0.1800 -4.600 4.910
Cash Flow per Share 2 3.630 3.500 0.1500 0.2300 0.6300 0.4000
Capex 1 0.1 0.17 0.47 0.1 0.1 -
Capex / Sales 0.58% 51.83% 15.33% 2.35% 1.99% -
Announcement Date 02/11/18 29/07/19 02/07/20 22/06/21 27/07/22 06/11/23
1CZK in Million2CZK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
ATOMTRACE Stock AtomTrace
-6.82% 7.77M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+12.96% 227B
DANAHER CORPORATION Stock Danaher Corporation
+13.44% 192B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+17.97% 136B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+28.33% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+1.67% 64.07B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+17.63% 52.1B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+7.04% 51.87B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+10.86% 44.33B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+6.31% 36.75B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. ATOMT Stock
  4. Financials AtomTrace